Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2008; 100(04): 611-613
DOI: 10.1160/TH08-06-0388
DOI: 10.1160/TH08-06-0388
Clinical Focus
Cardiovascular risk factors in patients at high risk of atherothrombosis: What can be learned from registries?
Further Information
Publication History
Received
19 June 2008
Accepted after minor revision
19 August 2008
Publication Date:
22 November 2017 (online)
-
References
- 1 Wilson PW. et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
- 2 Arcelus JI. et al. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost 2008; 99: 546-551.
- 3 Ruiz-Gimenez N. et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 26-31.
- 4 Blanco-Molina A. et al. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost 2007; 97: 186-190.
- 5 Falga C. et al. Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE registry. Thromb Haemost 2007; 98: 771-776.
- 6 Cohen AT. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
- 7 Ivaskevicius V. et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97: 914-921.
- 8 Fox KA. et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). Br Med J 2006; 333: 1091.
- 9 Bradshaw PJ. et al. Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set. Heart 2006; 92: 905-909.
- 10 Parikh NI. et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med 2008; 148: 102-110.
- 11 Touboul PJ. et al. Correlation between the Framingham risk score and intima media thickness: the Paroi Arterielle et Risque Cardio-vasculaire (PARC) study. Atherosclerosis 2007; 192: 363-369.
- 12 Wang TJ. et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. J Am Med Assoc 2003; 290: 1049-1056.
- 13 Gordon T. et al. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet 1974; 02: 1345-1348.
- 14 Freund KM. et al. The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol 1993; 03: 417-424.
- 15 Kannel WB. et al. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85-91.
- 16 Wilson PW. et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-1872.
- 17 Rosito GA. et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 2004; 91: 683-689.
- 18 Teo KK. et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-658.
- 19 Rosengren A. et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 953-962.
- 20 Verschuren WM. et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. J Am Med Assoc 1995; 274: 131-136.
- 21 Tunstall-Pedoe H. et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-1557.
- 22 Kubo M. et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349-2354.
- 23 Katsuki S. et al. Epidemiological Studies on Cer-ebrovascular Diseases in Hisayama, Kyushu Island, Japan. I. With Particular Reference to Cardiovascular Status. Jpn Heart J 1964; 127: 12-36.
- 24 Kiyohara Y. et al. Ten-year prognosis of stroke and risk factors for death in a Japanese community: the Hisayama study. Stroke 2003; 34: 2343-2347.
- 25 Ueda K. et al. Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke 1988; 19: 48-52.
- 26 Fujishima M. et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 1996; 45 (Suppl. 03) S14-6.
- 27 Ohmori S. et al. Hyperinsulinaemia and blood pressure in a general Japanese population: the Hisayama Study. J Hypertens 1994; 12: 1191-1197.
- 28 Saito T. et al. Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. J Periodontal Res 2005; 40: 346-353.
- 29 Ueda K. et al. Prevalence and long-term prognosis of mild hypertensives and hypertensives in a Japanese community, Hisayama. J Hypertens 1988; 06: 981-989.
- 30 Fujii I. et al. Natural history of borderline hypertension in the Hisayama community, Japan--I. The relative prognostic importance of transient variability in blood pressure. J Chronic Dis 1984; 37: 895-902.
- 31 Final report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research Group. N Engl J Med. 1989 321. 129-135.
- 32 Patrono C. et al. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353: 2373-2383.
- 33 Worth RM. et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol 1975; 102: 481-490.
- 34 Ro A. et al. The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism. Thromb Haemost 1999; 82: 1769.
- 35 Ozawa T. et al. Absence of factor V Leiden in the Japanese. Thromb Res 1996; 81: 595-596.
- 36 Bhatt DL. et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. J Am Med Assoc 2006; 295: 180-189.
- 37 Yamazaki T. et al. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J 2007; 71: 995-1003.
- 38 Ohman EM. et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006 151. 786 e1–10.
- 39 Steg PG. et al. One-year cardiovascular event rates in outpatients with atherothrombosis. J Am Med Assoc 2007; 297: 1197-1206.